Beta-caryophyllene (topical 20%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Beta-caryophyllene (topical 20%), covering 2020-01-06 to 2020-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee [Phase 2]